Specifically, I present evidence that these mechanisms regulate robustness allowing unstable systems to survive long periods of time, and thus they provide opportunity for other mutations to compensate the destabilizing effects of functionally innovative mutations.
In an innovative, mutation-based learning (MBL) approach, students were instructed to redesign a teacher-designed standard experimental protocol by a "mutation" method in a molecular genetics laboratory course.
The innovative mutation-based learning approach (MBL) was created to encourage students to propose redesigns of teacher-designed experiments and to then conduct both teacher-designed and student-designed experiments for comparison.
Consequently, evolution of biological innovation is dependent upon the fixation of mutations close in the structure that can compensate the destabilising effects of innovative mutations.
Alternatively, proteins that are already performing important functions are highly constrained and therefore might have more need of chaperone-assisted folding following the fixation of functionally innovative mutations.
As discussed above, our results support the hypothesis that chaperones facilitate adaptive evolution under the condition that functionally innovative mutations tend to interfere with protein folding.
First, proteins that are buffered by chaperones might be able to more easily fix functionally innovative mutations despite their structurally destabilizing effects.
This enhances the idea that evolvability, or the ability of finding beneficial or innovative mutations, could be a selected trait in bacterial sncRNAs.
In support of the co-evolutionary hypothesis as a mean to fix innovative mutations in the RbcL subunit, previous research has shown that when multiple amino acid replacements are introduced, significant changes can occur in both enzyme catalytic efficiency and specificity [ 64].
Potential adverse events In the innovative treatment, BRCA1/2 mutation carriers will undergo an additional laparoscopy.
Furthermore, insights into the mechanism of action of the BRCA1/2 genes could in turn facilitate research efforts aimed at finding innovative preventive management options for BRCA1/2 mutation carriers.
